Zhejiang NHU reports strong Q3 results, adjusts related-party sales forecast

Zhejiang NHU Company Ltd. reported a significant increase in net profit attributable to shareholders, rising 33.37% year-on-year to RMB 5.32 bn for Q1-Q3 2025, with operating revenue up 5.45% to RMB 16.64 bn. Basic and diluted EPS for the period reached RMB 1.73, marking a 34.11% increase. The company's total assets grew by 4.90% to RMB 45.09 bn, and net assets attributable to shareholders increased by 9.81% to RMB 32.20 bn as of September 30, 2025.

The board of directors also approved an adjustment to the 2025 forecast for daily related-party transactions. The projected related-party procurement for sales services of liquid methionine to Zhejiang Ningbo Zhenhai Refinery NHU Biotechnology Co., Ltd. (Zhenxin Biology) increased by CNY 145 m, bringing the total estimated related-party transactions for 2025 to CNY 781.36 m from CNY 636.36 m. This adjustment is due to Zhenxin Biology's increased liquid methionine production capacity and growing overseas market demand.

In other news, the company completed a share repurchase program, acquiring 14,815,692 shares (0.4820% of total capital) for RMB 321.41 m. The 2025 interim profit distribution of RMB 2.00 per 10 shares was finalized on October 20, 2025. Additionally, the company is seeking registration to issue debt financing instruments up to RMB 3 bn to fund operations and reduce financing costs.